Compare BET to something like BRN and you will very quickly see how incredibly undervalued BET is.
Market capitalisation of approx $250m vs $1B+ for BRN. $61m cash and zero debt with $100m+ annual revenue for BET vs negligible revenue for BRN and $23m cash.
Only reason BET has been put in this position vs other growth stocks is because of the large honeypot block of shares that shorts had access to. Fundamentals have been irrelevant
but the worm could be turning here with a very competent person now in charge of the ship and clear path ahead.
Early volume looking good to.
IMO DYOR
- Forums
- ASX - By Stock
- BET
- Ann: Q2 FY23 Quarterly Activities Report and Appendix 4C
Ann: Q2 FY23 Quarterly Activities Report and Appendix 4C, page-21
-
- There are more pages in this discussion • 170 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BET (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.5¢ |
Change
0.003(2.72%) |
Mkt cap ! $92.16M |
Open | High | Low | Value | Volume |
9.0¢ | 9.5¢ | 9.0¢ | $36.44K | 395.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 50769 | 9.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.5¢ | 65022 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 50769 | 0.093 |
3 | 67125 | 0.092 |
2 | 40729 | 0.091 |
2 | 206700 | 0.090 |
1 | 13449 | 0.089 |
Price($) | Vol. | No. |
---|---|---|
0.095 | 65022 | 3 |
0.096 | 56497 | 2 |
0.097 | 72486 | 2 |
0.098 | 6401 | 1 |
0.099 | 87950 | 2 |
Last trade - 13.48pm 12/11/2024 (20 minute delay) ? |
Featured News
BET (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online